Genotype-phenotype correlation for pulmonary function in cystic fibrosis

Area of Science:

• Genetics
• Pulmonology
• Medical Research

Background:

• Over 1000 cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations identified.
• Established genotype-phenotype correlations for CF lung disease progression remain unclear.
• Study investigates CFTR genotype, lung disease progression, and survival in adults.

Purpose of the Study:

• To analyze the relationship between CFTR genotype and lung disease progression in adult CF patients.
• To determine the impact of CFTR mutation class and molecular position on disease severity and survival.
• To compare clinical characteristics and outcomes based on CFTR mutation groupings.

Main Methods:

• Prospective cohort study of adult CF patients with two CFTR mutations.
• Classification of patients based on CFTR mutation functional effects and molecular position (e.g., I-II/I-II, I-II/III-V).
• Analysis of spirometry, lung disease progression, survival probability, and clinical data.

Main Results:

• Seventy-four adult CF patients included.
• Genotype I-II/I-II associated with significantly lower spirometry (p < 0.001) and greater pulmonary function loss (p < 0.04).
• Patients with I-II/I-II genotype showed higher rates of end-stage lung disease (p < 0.001), increased risk of severe disease (OR 7.12), and lower survival probability (p < 0.001).

Conclusions:

• Dual class I or II CFTR mutations correlate with more severe respiratory disease.
• Presence of class I or II mutations on both CFTR alleles is linked to a reduced probability of survival.
• Genotype-specific outcomes highlight the need for tailored CF management strategies.